Drawing based on the label description. No photo yet.
INCY 15 pill
Pill with imprint INCY 15 is white, oval, 15 mm and has been identified as Ruxolitinib 15.0 mg. It is used for polycythemia vera and primary myelofibrosis. It is supplied by Incyte Corporation.
Ruxolitinib 15.0 mg
- Imprint
- INCY 15
- Strength
- 15.0 mg
- Used for
- Polycythemia vera and primary myelofibrosis
- Color
- White
- Shape
- Oval
- Size
- 15 mm
- Score
- No score line
- Form
- Tablet
- Manufacturer
- Incyte Corporation
- Drug class
- Cancer medicine (kinase inhibitor)
- NDC
- 50881-015, 50881-015-60
Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .
Report a mistake
What is Ruxolitinib used for?
Ruxolitinib is used for polycythemia vera and primary myelofibrosis.
- Medicine type
- Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label
Myelofibrosis
JAKAFI/JAKAFI XR is indicated for treatment of intermediate or high-risk myelofibrosis (MF), including primary MF, post-polycythemia vera MF, and post-essential thrombocythemia MF in adults.
Polycythemia Vera
JAKAFI/JAKAFI XR is indicated for treatment of polycythemia vera (PV) in adults who have had an inadequate response to or are intolerant of hydroxyurea.
Acute Graft-Versus-Host Disease
JAKAFI/JAKAFI XR is indicated for treatment of steroid-refractory acute graft-versus-host disease (aGVHD) in adult and pediatric patients 12 years and older.
Chronic Graft-Versus-Host Disease
JAKAFI/JAKAFI XR is indicated for treatment of chronic graft-versus-host disease (cGVHD) after failure of one or two lines of systemic therapy in adult and pediatric patients 12 years and older.
From the FDA-approved label on DailyMed (published Aug 03, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your pill? Check every detail
- Your pill shows INCY 15. The parts can be split between the two sides, so turn the pill over and check both.
- It is white, oval, 15 mm.
- Its score line and coating match the details on this page.
- It came from a pharmacy package that names the same drug.
Sold under the brand name Jakafi.
Ingredients
Active: Ruxolitinib
Inactive: Cellulose, Microcrystalline, Lactose Monohydrate, Silicon Dioxide, Hydroxypropyl Cellulose (70000 Wamw), Povidone, Sodium Starch Glycolate Type A Potato, Magnesium Stearate
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
-
G520
Metformin Hydrochloride 500 mg
White, oval, 14 mm
Used for type 2 diabetes
-
CP 296
Ultramicrosize Griseofulvin Tablets 250 mg
White, oval, 14 mm
-
G 600
Guaifenesin 600 mg
White, oval, 16 mm
Used for bronchitis and year-round allergies
-
G 135
Abiraterone Acetate 250 mg
White, oval, 16 mm
Used for castration-resistant prostatic neoplasms
-
438
Olmesartan Medoxomil 40 mg
White, oval, 15 mm
Used for high blood pressure and heart failure
-
U11 Breakline
Ursodiol 500 mg
White, oval, 16 mm
Used for cholelithiasis and biliary liver cirrhosis
Other Ruxolitinib pills
- NVR L10 Ruxolitinib Phosphate 10 mg White, round Used for polycythemia vera and primary myelofibrosis
- INCY 10 Ruxolitinib 10.0 mg White, round, 9 mm Used for polycythemia vera and primary myelofibrosis
- I 11 Ruxolitinib 11 mg Pink, round, 9 mm Used for polycythemia vera and primary myelofibrosis
- NVR L15 Ruxolitinib Phosphate 15 mg White, oval Used for polycythemia vera and primary myelofibrosis
- NVR L20 Ruxolitinib Phosphate 20 mg White, capsule Used for polycythemia vera and primary myelofibrosis
- INCY 20 Ruxolitinib 20.0 mg White, capsule, 16 mm Used for polycythemia vera and primary myelofibrosis
- I 22 Ruxolitinib 22 mg Yellow, round, 9 mm Used for polycythemia vera and primary myelofibrosis
- INCY 25 Ruxolitinib 25.0 mg White, oval, 18 mm Used for polycythemia vera and primary myelofibrosis